Global Vascular Closure Devices Market size is expected to be worth around US$ 3.4 Billion by 2034 from US$ 1.7 Billion in ...

VCD Medical, an Italy-based company developing novel, minimally invasive vein closure technologies, has received U.S. Food and Drug Administration (FDA) 510 (k) clearance for its VEnice™ Vein Closure ...

Austin, June 23, 2025 (GLOBE NEWSWIRE) -- Vascular Closure Devices Market Size & Growth Analysis: According to SNS Insider, the Vascular Closure Devices Market was valued at USD 1.78 billion in 2024 ...

According to a Comprehensive Research Report by Market Research Future (MRFR), “Vascular Closure Device Market Information by Type, Access, Procedure, Application, End-User, and Region - Forecast till ...

Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...

Haemonetics Corporation HAE recently gained CE mark certification for the VASCADE vascular closure and VASCADE MVP venous vascular closure systems. The VASCADE system is intended for ‘small-bore’ ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that it will unveil the results of its U.S ...

WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...

The explosion of innovation in valve replacement and repair markets is opening a huge opportunity for percutaneous vessel closure devices. Edward Lifesciences’s FDA nod for the Evoque Transcatheter ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...